Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The Limits to Governance
Does the state still frame debates about new technology? Can policy-makers ensure the benefits of health developments through genomics while still satisfying the expectations of society and the economic imperatives? In this critique of the new governance agenda for research and innovation in life sciences, the authors discuss the world-wide policy decisions needed, with particular reference to genomics. They suggest the many facets of policy and could be treated as a government-governance continuum, where different aspects of genomics may sit at different points, and co-exist. Their findings offer valuable insights for the future and will help promote a global solution to this problem.
Medical Use of Illicit Drugs
With the legalization of medical marijuana becoming increasingly common in many states, the medicinal potential of formerly illicit drugs has caught the public's attention. However, marijuana is not the only drug being researched and used medicinally: MDMA, psilocybin, and ketamine have been found to have therapeutic qualities, which leads some to question whether the medical use of these substances may also be legal in the future. This volume helps readers explore issues like regulation, the ethics of using illicit drugs in medical and scientific research, and its place in the greater history of drug regulation in the United States.
Mother of Invention
Underlying America's robust private health care industry is an indispensible partner that has guided and supported it for over half a century: the government. This book demonstrates how government initiatives created American health care as we know it today and places the Obama plan in its true historical and political context.
Curious2018
This book expands the debate on the future of science and technology at the Curious2018 – Future Insight Conference, held on the occasion of Merck’s 350-year anniversary. In the respective chapters, some of the world’s top scientists, managers and entrepreneurs explore breakthrough technologies and how they can be applied to make a better world for humanity. Divided into three parts, the book begins with an introduction to the vision of the conference and to the importance of curiosity for innovation, while also exploring the latest scientific developments that are shaping the future of healthcare, medicine, the life and material sciences, digitalization and new ways of working togethe...
Pediatric Drug Development
Pediatric Drug Development: Concepts and Applications is designed as a reference and textbook and is meant to address the science of differences between the pediatric and adult subject in the development of pharmaceutical products. Considered are the ethics and medical needs of proper understanding the pediatric and adult differences, the business case for proper development of drugs for children, as well as the technical feasibility studies and processes that are necessary for a proper pediatric drug development program. The applications of these approaches will benefit all stakeholders and ultimately not only educate but also provide better and safer drugs for pediatric patients.
The New Health Bioeconomy
This book provides new insights into how new biology, and the emergence of "translational" policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new therapies. A key argument is that a broader definition of value (beyond the economic aspects) is needed to understand health innovation in the twenty-first century.
The Challenges of the New EU Pharmaceutical Legislation
In the domain of public policy on pharmaceuticals, protecting public health requires a dual strategy: robust regulation on the one hand and stimulation of competitiveness and innovation on the other. Regulation must be robust to ensure that only medicines meeting exact standards of safety, quality and efficacy are authorised for human and animal use. At the same time competitiveness and innovation must be stimulated. Without innovation in pharmaceuticals, the incurable diseases of today will remain incurable. Competitiveness drives innovation and innovation saves lives. Increased competitiveness of the pharmaceutical sector will not only better protect public health, but will also create high quality jobs and create growth. In this context the implementation of the G10 recommendations, particularly regarding the pricing and reimbursement of medicines by Member States, remains a considerable challenge.
Cultural Turns
The contemporary fields of the study of culture, the humanities and the social sciences are unfolding in a dynamic constellation of cultural turns. This book provides a comprehensive overview of these theoretically and methodologically groundbreaking reorientations. It discusses the value of the new focuses and their analytical categories for the work of a wide range of disciplines. In addition to chapters on the interpretive, performative, reflexive, postcolonial, translational, spatial and iconic turns, it discusses emerging directions of research. Drawing on a wealth of international research, this book maps central topics and approaches in the study of culture and thus provides systematic impetus for changed disciplinary and transdisciplinary research in the humanities and beyond – e.g., in the fields of sociology, economics and the study of religion. This work is the English translation by Adam Blauhut of an influential German book that has now been completely revised. It is a stimulating example of a cross-cultural translation between different theoretical cultures and also the first critical synthesis of cultural turns in the English-speaking world.
Pharmacotherapy of Child and Adolescent Psychiatric Disorders
This book fulfils an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or bipolar disorder, but who are deemed to be at high risk. This is an active area of debate: such children are being treated in certain centers, while others reject this completely. The book addresses the antidepressant controversy, the placebo response and unique strategies for delineating this, and ways to optimize the differential between ac...
A Clinical Trials Manual From The Duke Clinical Research Institute
"The publication of the second edition of this manual comes at an important juncture in the history of clinical research. As advances in information technology make it possible to link individuals and groups in diverse locations in jointly seeking the answers to pressing global health problems, it is critically important to remain vigilant about moral and ethical safeguards for every patient enrolled in a trial. Those who study this manual will be well aware of how to ensure patient safety along with fiscal responsibility, trial efficiency, and research integrity." —Robert Harrington, Professor of Medicine, Director, Duke Clinical Research Institute, Durham, North Carolina, USA The Duke Cl...
